A list of downloadable documents created during development.

Background information

Final Appraisal Determination: The use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes

Appraisal Consultation Document: Glycoprotein IIb/IIIa Inhibitors

Assessment report: Glycoprotein IIb/IIIa Antagonists

Cost-effectiveness model: Glycoprotein Antagonists

A Systematic Review Update of the Clinical Effectiveness and Cost Effectiveness of Glycoprotein IIb/IIIa Antagonists